Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Incannex Healthcare (IXHL) over the last 3 years, with Q3 2025 value amounting to $310.3 million.

  • Incannex Healthcare's Shares Outstanding (Weighted Average) rose 165884.27% to $310.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.3 million, marking a year-over-year increase of 165884.27%. This contributed to the annual value of $34.5 million for FY2025, which is 11314.99% up from last year.
  • Per Incannex Healthcare's latest filing, its Shares Outstanding (Weighted Average) stood at $310.3 million for Q3 2025, which was up 165884.27% from $34.5 million recorded in Q2 2025.
  • In the past 5 years, Incannex Healthcare's Shares Outstanding (Weighted Average) registered a high of $310.3 million during Q3 2025, and its lowest value of $15.9 million during Q3 2023.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $51.5 million, with a median of $17.6 million in 2024.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 1103.32% in 2024, then skyrocketed by 165884.27% in 2025.
  • Incannex Healthcare's Shares Outstanding (Weighted Average) (Quarter) stood at $15.9 million in 2023, then grew by 11.03% to $17.6 million in 2024, then soared by 1660.68% to $310.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $310.3 million in Q3 2025, compared to $34.5 million in Q2 2025 and $19.6 million in Q1 2025.